Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:729-736, doi:10.1016/S0735-1097(02)02927-3
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmer, B. R.
Right arrow Articles by Cameron, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmer, B. R.
Right arrow Articles by Cameron, V. A.

CLINICAL STUDY: ACUTE CORONARY SYNDROME

Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction

Barry R. Palmer, PhD*, Anna P. Pilbrow, BSc (Hons)*, Tim G. Yandle, PhD*, Chris M. Frampton, PhD*, A. Mark Richards, MD*, M. Gary Nicholls, MD, FACC* and Vicky A. Cameron, PhD*,*

* Christchurch Cardioendocrine Research Group, Department of Medicine, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand

Manuscript received July 31, 2002; revised manuscript received October 28, 2002, accepted November 19, 2002.

* Reprint requests and correspondence: Dr. Vicky A. Cameron, Department of Medicine, Christchurch School of Medicine and Health Sciences, P.O. Box 4345, Christchurch, New Zealand.
vicky.cameron{at}chmeds.ac.nz

OBJECTIVES: The goal of this study was the exploration of the associations between the angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism and post-myocardial infarction (MI) outcomes, especially any interaction with the accepted clinical prognostic markers brain natriuretic peptide (BNP) and left ventricular ejection fraction (LVEF).

BACKGROUND: The ACE gene I/D polymorphism has been implicated in the development of MI, hypertension, and left ventricular hypertrophy. We examined the association of ACE I/D and prognosis after acute MI.

METHODS: Patients incurring acute MI were genotyped for the ACE I/D polymorphism. Clinical data included assays of neurohormones, radionuclide ventriculography, and mortality over a mean 2.6 years of follow-up.

RESULTS: Patients (n = 978) had a mean age of 62.1 years, and 78% were male. Overall genotype frequencies were II 23.2%, ID 49.5%, and DD 27.3%. Chi-square analysis revealed an association between the ACE D allele and death after MI (88 of 103 who died were DD or ID; p < 0.05), with an odds ratio for mortality of 8.03 (95% confidence interval, 2.16 to 29.88). Patients with the DD genotype had higher (p < 0.05) plasma BNP, N-terminal BNP (N-BNP), and endothelin-1 levels within 96 h after MI than grouped ID/II patients. Multivariate analysis indicated ACE genotype, age, and previous MI were independent predictors of death (p < 0.05). Patients with an ACE D allele in combination with either a lower than median LVEF or greater than median BNP had a higher mortality (p < 0.001 and p < 0.025, respectively) than the risk associated with the D allele itself.

CONCLUSIONS: Angiotensin-converting enzyme genotyping may provide additional prognostic information in patients after MI in combination with the proven utility of LVEF, plasma BNP, and N-BNP measurements.

Abbreviations and Acronyms
  ACE
  angiotensin-converting enzyme
  AII
  angiotensin II
  ANP
  atrial natriuretic peptide
  ApoE
  apolipoprotein E
  BMI
  body mass index
  BNP
  brain natriuretic peptide
  DNA
  deoxyribonucleic acid
  I/D
  insertion/deletion
  LV
  left ventricle/ventricular
  LVEF
  left ventricular ejection fraction
  MI
  myocardial infarction
  N-BNP
  N-terminal brain natriuretic peptide
  PCR
  polymerase chain reaction
  PMI
  Christchurch Post-Myocardial Infarction study
  RAAS
  renin-angiotensin-aldosterone system




This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. Settin, R. ElBaz, A. Abbas, A. Abd-Al-Samad, and A. Noaman
Angiotensin-converting enzyme gene insertion/deletion polymorphism in Egyptian patients with myocardial infarction
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2009; 10(2): 96 - 100.
[Abstract] [PDF]


Home page
Eur J Heart FailHome page
M. D. Littlejohn, B. R. Palmer, A. M. Richards, C. M. Frampton, A. P. Pilbrow, R. W. Troughton, V. A. Cameron, and M. A. Kennedy
Ile164 variant of {beta}2-adrenoceptor does not influence outcome in heart failure but may interact with {beta} blocker treatment
Eur J Heart Fail, January 1, 2008; 10(1): 55 - 59.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. J. Barrick, M. Rojas, R. Schoonhoven, S. S. Smyth, and D. W. Threadgill
Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2119 - H2130.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
V Teplitsky, Y Shoenfeld, and A Tanay
The renin-angiotensin system in lupus: physiology, genes and practice, in animals and humans
Lupus, June 1, 2006; 15(6): 319 - 325.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
W. Koch, W. Latz, M. Eichinger, C. Ganser, A. Schomig, and A. Kastrati
Genotyping of the Angiotensin I-Converting Enzyme Gene Insertion/Deletion Polymorphism by the TaqMan Method
Clin. Chem., August 1, 2005; 51(8): 1547 - 1549.
[Full Text] [PDF]


Home page
CirculationHome page
S. Suzuki, M. Yoshimura, M. Nakayama, Y. Mizuno, E. Harada, T. Ito, S. Nakamura, K. Abe, M. Yamamuro, T. Sakamoto, et al.
Plasma Level of B-Type Natriuretic Peptide as a Prognostic Marker After Acute Myocardial Infarction: A Long-Term Follow-Up Analysis
Circulation, September 14, 2004; 110(11): 1387 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. R. Palmer, C. M. Frampton, A. M. Richards, V. A. Cameron, and T. Nakayama
Absence of a NPR-A Gene Functional Deletion Allele in a Postmyocardial Infarction Cohort From New Zealand
Circ. Res., May 28, 2004; 94(10): e86 - e86.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. M. Fernandez, J. J. Rodriguez Reguero, and P. Gonzalez
Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults
J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1864 - 1864.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. A. Cameron and B. R. Palmer
Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults: Reply
J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1864 - 1864.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement